IL-12 plus CTB in intranasal DNA-MVA schemes improved magnitude and quality of both systemic and mucosal HIV cellular immune responses

Ítems similars

• Novel Mucosal DNA-MVA HIV Vaccination in Which DNA-IL-12 Plus Cholera Toxin B Subunit (CTB) Cooperates to Enhance Cellular Systemic and Mucosal Genital Tract Immunity
  per: Maeto, Cynthia, et al.
  Publicat: (2014)
• IL-12 and GM-CSF in DNA/MVA Immunizations against HIV-1 CRF12_BF Nef Induced T-Cell Responses With an Enhanced Magnitude, Breadth and Quality
  per: Rodríguez, Ana María, et al.
  Publicat: (2012)
• Fusion-Expressed CTB Improves Both Systemic and Mucosal T-Cell Responses Elicited by an Intranasal DNA Priming/Intramuscular Recombinant Vaccinia Boosting Regimen
  per: Qiu, Sugan, et al.
  Publicat: (2014)
• Fusion-Expressed CTB Improves Both Systemic and Mucosal T-Cell Responses Elicited by an Intranasal DNA Priming/Intramuscular Recombinant Vaccinia Boosting Regimen
  per: Sugan Qiu, et al.
  Publicat: (2014-01-01)
• Improving the MVA Vaccine Potential by Deleting the Viral Gene Coding for the IL-18 Binding Protein
  per: Falivene, Juliana, et al.
  Publicat: (2012)